Lundbeck
HLUN-B.CO
#2810
Rank
A$7.07 B
Marketcap
$7.36
Share price
-5.43%
Change (1 day)
0.46%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): $0.53

According to Lundbeck 's latest financial reports the company's current EPS (TTM) is $0.59. In 2022 the company made an earnings per share (EPS) of $0.44 a decrease over its 2021 EPS that were of $1.00.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.5319.55%
2022$0.44-55.47%
2021$1.00-51.83%
2020$2.07-28.01%
2019$2.88-44.08%
2018$5.1551.94%
2017$3.39126.64%
2016$1.50-120.84%
2015-$7.185622.18%
2014-$0.13-110.03%
2013$1.25-28.08%
2012$1.74-52.1%
2011$3.63-1.31%
2010$3.6815.61%
2009$3.18